Politics

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/10/2026, 11:24:25 UTC.

Briefings

Alicia Jackson, director of ARPA-H, endorsed a federal policy removing black box warnings from hormone replacement therapies while holding undisclosed financial interests in Evernow, a company she founded. She received a conflict waiver allowing her to participate in funding decisions related to her husband's investments, yet her financial disclosures remain uncertified. HHS placed her on administrative leave pending an ethics review, and the Trump administration's ethics office does not list her as having received a waiver.

Key points

• Alicia Jackson, director of ARPA-H, endorsed the removal of black box warnings from hormone replacement therapies while holding undisclosed financial interests in Evernow, a company she founded.
• HHS placed Alicia Jackson on administrative leave pending an ethics review, and the Office of Government Ethics does not list her as having received a conflict waiver despite her husband's investments.

Context

The U.S. Department of Health and Human Services announced the elimination of black box warnings on hormone replacement therapies to reverse decades of stigma. Alicia Jackson, a former Evernow founder, endorsed this policy while retaining stock in her company, raising concerns about potential conflicts of interest and ethical violations.

Limitations

Financial disclosure records for Alicia Jackson remain uncertified, and HHS declined to provide details on the reasons for her leave or the status of the conflict waiver. The Trump administration's ethics office does not list her as having received a waiver, and the Office of Government Ethics does not list her among officials with waivers.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/10/2026, 06:31:47 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidcxykrbxgrw7xnbfummzoqwafjgmwvh4aehk4wr3vnefcgl52cam